Department of Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas.
Department of Emergency Medicine, University of Arizona College of Medicine, Tucson, Arizona.
J Emerg Med. 2021 Dec;61(6):801-809. doi: 10.1016/j.jemermed.2021.07.060. Epub 2021 Sep 15.
Syncope is a common presentation to the emergency department (ED). A significant minority of these patients have potentially life-threatening pathology. Reliably identifying that patients require hospital admission for further workup and intervention is imperative.
In patients who present with syncope, is there a reliable decision tool that clinicians can use to predict the risk of adverse outcome and determine who may be appropriate for discharge?
Four articles were reviewed. The first retrospective study found no difference in mortality or adverse events in patients admitted for further evaluation rather than discharged home with primary care follow-up. The next two articles examined the derivation and validation of the Canadian Syncope Risk Score (CSRS). After validation with an admission threshold score of -1, the sensitivity and specificity of the CSRS was 97.8% (95% confidence interval [CI] 93.8-99.6%) and 44.3% (95% CI 42.7-45.9%), respectively. The last article looked at the derivation of the FAINT score, a recently developed score to risk stratify syncope patients. A FAINT score of ≥ 1 (any score 1 or higher should be admitted) had a sensitivity of 96.7% (95% CI 92.9-98.8%) and specificity 22.2% (95% CI 20.7-23.8%).
Syncope remains a difficult chief symptom to disposition from the ED. The CSRS is modestly effective at establishing a low probability of actionable disease or need for intervention. However, CSRS might not reduce unnecessary hospitalizations. The FAINT score has yet to undergo validation; however, the initial derivation study offers less diagnostic accuracy compared with the CSRS.
晕厥是急诊科(ED)常见的就诊原因。少数此类患者存在潜在危及生命的病理。可靠地识别出需要住院进一步检查和干预的患者至关重要。
在出现晕厥的患者中,是否有可靠的决策工具可以帮助临床医生预测不良结局的风险,并确定哪些患者适合出院?
共综述了 4 篇文章。第一项回顾性研究发现,进一步评估后住院的患者与主要医疗随访后出院的患者在死亡率或不良事件方面没有差异。接下来的两项研究探讨了加拿大晕厥风险评分(CSRS)的推导和验证。在采用入院阈值评分-1 进行验证后,CSRS 的灵敏度和特异性分别为 97.8%(95%置信区间[CI] 93.8-99.6%)和 44.3%(95% CI 42.7-45.9%)。最后一篇文章研究了 FAINT 评分的推导,FAINT 评分是一种新开发的用于分层晕厥患者风险的评分。FAINT 评分≥1(任何评分 1 或更高都应入院)的灵敏度为 96.7%(95% CI 92.9-98.8%),特异性为 22.2%(95% CI 20.7-23.8%)。
晕厥仍然是急诊科处理困难的主要症状。CSRS 在确定低概率的可操作疾病或需要干预方面具有一定的效果。然而,CSRS 可能并不能减少不必要的住院治疗。FAINT 评分尚未经过验证;然而,初步推导研究与 CSRS 相比,其诊断准确性较低。